KOLMAR BNH CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15,990 KRW | +0.76% |
|
-2.62% | -10.87% |
| May. 28 | Kolmar BNH Expands Its Global Market by Launching HemoHIM G in Taiwan | CI |
| May. 16 | KOLMAR BNH Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Sales 2022 | 576B 419M | Sales 2023 | 580B 422M | Capitalization | 522B 380M |
|---|---|---|---|---|---|
| Net income 2022 | 40.51B 29.49M | Net income 2023 | 19.71B 14.35M | EV / Sales 2022 | 1.53 x |
| Net Debt 2022 | 46.41B 33.79M | Net Debt 2023 | 121B 88.33M | EV / Sales 2023 | 1.11 x |
| P/E ratio 2022 |
20.6
x | P/E ratio 2023 |
26.6
x | Employees | 495 |
| Yield 2022 |
1.09% | Yield 2023 |
1.72% | Free-Float | 39.27% |
More Fundamentals
* Assessed data
More news
| 1 day | +0.76% | ||
| 1 week | -2.62% | ||
| Current month | +0.76% | ||
| 1 month | +1.65% | ||
| 3 months | +3.56% | ||
| 6 months | +3.09% | ||
| Current year | -10.87% |
1 week
15 500.00
16 550.00
1 month
15 460.0016 890.00
Current year
14 210.0018 320.00
1 year
14 210.0021 850.00
3 years
14 210.0052 300.00
5 years
14 210.0072 900.00
10 years
14 210.0072 900.00
| Managers | Title | Age | Since |
|---|---|---|---|
Hwa-Young Jung
CEO | Chief Executive Officer | 59 | 13-01-01 |
Yeo-Won Yoon
CEO | Chief Executive Officer | 48 | 15-08-19 |
Kwang-Il Kim
AUD | Comptroller/Controller/Auditor | 60 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Yeo-Won Yoon
CEO | Chief Executive Officer | 48 | 15-08-19 |
Byeong-Mook Kim
BRD | Director/Board Member | 63 | 17-03-23 |
Hwa-Young Jung
CEO | Chief Executive Officer | 59 | 13-01-01 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 4 M€ | -4.41% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-06-02 | 15,990 | +0.76% | 85 939 |
| 24-05-31 | 15,870 | -0.81% | 315,658 |
| 24-05-30 | 16,000 | +1.14% | 58,889 |
| 24-05-29 | 15,820 | +0.83% | 58,140 |
| 24-05-28 | 15,690 | -2.85% | 79,554 |
End-of-day quote Korea S.E., June 02, 2024
More quotes
KolmarBNH Co., Ltd, formerly MIRAE ASSET NO.2 SPECIAL PURPOSE ACQUISITION COMPANY, is a Korea-based company principally engaged in manufacture and distribution of health functional foods, cosmetics and pharmaceuticals. The Company mainly produces health functional foods to improve immunity, such as atomy hemohims and others. The Company also produces cosmetics using natural extracts, and other pharmaceuticals. The Company also engages in research, development and manufacture of cosmetic functional materials which belongs to phytochemical business that mainly uses natural extracts as cosmetic materials.
Sector
Food Processing
Calendar
2024-08-12
- Q2 2024 Earnings Release (Projected)
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -10.87% | 333M | |
| +4.94% | 7.59B | |
| -0.05% | 6.07B | |
| -3.99% | 3.85B | |
| -11.92% | 3.55B | |
| -10.53% | 1.28B | |
| -33.16% | 1.03B | |
| +14.51% | 971M | |
| -9.51% | 907M | |
| -14.12% | 813M |
- Stock Market
- Equities
- A200130 Stock
